Insmed Inc. buy Royal Bank of Canada
Start price
08.05.26
/
50%
€84.57
Target price
08.05.27
€174.80
Performance (%)
6.47%
Price
29.07.26
€90.43
Summary
This prediction is currently active. With a performance of 6.47%, the BUY prediction by Royal_Bank_of_Canada for Insmed Inc. is trending in the right direction. This prediction currently runs until 08.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Royal Bank Of Canada from $220.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat

